|
Video: What is a Stock Split?
|
|
Sio Gene Therapies is a clinical-stage biopharmaceutical company focused on gene therapy for neurological diseases. Co. is developing a pipeline of product candidates as the following: AXO-Lenti-PD, which is developed for the treatment of Parkinson's disease; AXO-AAV-GM1, which is an investigational gene therapy that is being developed as a potential one-time disease modifying treatment for GM1 gangliosidosis; and AXO-AAV-GM2, which is an investigational gene therapy that Co. is developing as a potential one-time disease modifying treatment for GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease). According to our AXGT split history records, AXGT has had 1 split. | |
|
AXGT (AXGT) has 1 split in our AXGT split history database. The split for AXGT took place on May 08, 2019. This was a 1 for 8 reverse split, meaning for each 8 shares of AXGT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split.
When a company such as AXGT conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the AXGT split history from start to finish, an original position size of 1000 shares would have turned into 125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AXGT shares, starting with a $10,000 purchase of AXGT, presented on a split-history-adjusted basis factoring in the complete AXGT split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/12/2015 |
|
End date: |
11/12/2020 |
|
Start price/share: |
$178.48 |
|
End price/share: |
$2.10 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.82% |
|
Average Annual Total Return: |
-55.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$117.67 |
|
Years: |
5.42 |
|
|
|
Date |
Ratio |
05/08/2019 | 1 for 8 |
|
|